2026-10-28 15:33 |
Detailed record - Similar records
|
2026-10-28 15:31 |
Detailed record - Similar records
|
2026-10-28 15:28 |
[DZNE-2026-01112]
Journal Article
Valentim, C. ; Denecke, J. ; Frerich, S. ; et al
Pathway-specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease.
Genome-wide association studies (GWASs) identified multiple genetic variants associated with Alzheimer's disease (AD) risk, yet the biological pathways linking these to amyloid and tau pathology remain unclear.We conducted a meta-analysis of recent GWASs to identify independent genome-wide significant single nucleotide polymorphisms which were mapped via gene-set enrichment to derive pathway-specific polygenic risk scores (pPRSs). Analyses included 441 amyloid-positive participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI; 224 with longitudinal tau positron emission tomography [PET]) and 250 amyloid-positive participants from the Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) study (113 with longitudinal tau PET). [...]
Restricted: PDF PDF (PDFA);
Detailed record - Similar records
|
2026-10-28 15:23 |
Detailed record - Similar records
|
2026-10-28 15:15 |
Detailed record - Similar records
|
2026-10-28 15:07 |
[DZNE-2026-01109]
Journal Article
Kokolahti, A. ; Puustinen, S. ; Russek, M. ; et al
Risk-of-Bias Assessment of Target Trial Emulation Studies at Regulatory and Policy Decision Points Along the Medical Product Life Cycle: Protocol for a Scoping Review and Stakeholder Survey.
Target trial emulation (TTE) studies are increasingly important for regulatory decision‑making and health technology assessments (HTAs), but current risk-of-bias (RoB) tools are not specifically tailored to assess biases central to TTE studies-such as immortal time bias, misaligned eligibility criteria, and prevalent user bias. RoB assessment for TTE studies thus remains difficult, and it is unclear which tools and adaptations researchers currently use or how well they work.This study aims to analyze the RoB assessment of TTE studies at regulatory and policy decision points along the medical product life cycle by providing a systematic overview of tools developed, used, adapted, or evaluated for TTE studies and the perceived importance and feasibility of assessing TTE studies by HTA assessors, regulators, systematic reviewers, and methods experts.This is a protocol for a scoping review and online survey among systematic reviewers, methods experts, European HTA organizations, and regulators. [...]
Restricted: PDF PDF (PDFA);
Detailed record - Similar records
|
2026-10-26 08:49 |
Detailed record - Similar records
|
2026-10-26 08:44 |
Detailed record - Similar records
|
2026-10-26 08:34 |
Detailed record - Similar records
|
2026-10-26 08:29 |
Detailed record - Similar records
|
|
|